Mahamaya Lifesciences Quarterly Results
Mahamaya Lifesciences quarterly results. In Mar 2025, Mahamaya Lifesciences (MAHALIFE) reported revenue ₹118 Cr and net profit ₹5 Cr. View Mahamaya Lifesciences yearly highs lows for the annual high/low range and current price position.
MAHALIFE Quarterly Results — Revenue, Profit & EPS Highlights
Mahamaya Lifesciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore MAHALIFE share price data to track price trends across different timeframes.
- Revenue of ₹118 Cr in Mar 2025
- Net Profit of ₹5 Cr in Mar 2025
- EBITDA of ₹10 Cr in Mar 2025
- Operating Margin of 8.0% in Mar 2025
- Earnings Per Share of ₹3.04 in Mar 2025
Mahamaya Lifesciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS
MAHALIFE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2025 | Dec 2024 | QoQ | YoY |
|---|---|---|---|---|
| Revenue (₹ Cr) | 118 | 0 | - | - |
| Net Profit (₹ Cr) | 5 | 0 | - | - |
| EBITDA (₹ Cr) | 10 | 0 | - | - |
| EPS (₹) | 3.04 | 0.00 | - | - |
| Operating Margin (%) | 8.0% | 0.0% | - | - |
MAHALIFE Share Price Trend — 1-Year Movement Across Quarterly Results
Mahamaya Lifesciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit MAHALIFE stock price BSE.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
MAHALIFE vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Mahamaya Lifesciences latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Solar Industries
Sept 2026 |
₹170,302.28 Cr | 18850.0 | 3,534 | 650 | +14.0% | - | 18.4% | 276.4 |
|
Pidilite Industries
Sept 2026 |
₹155,755.95 Cr | 1580.5 | 4,367 | 627 | +19.7% | - | 14.4% | 261.7 |
|
SRF
Sept 2026 |
₹72,475.87 Cr | 2513.9 | 4,828 | 509 | +5.9% | - | 10.5% | 146.3 |
|
Linde
Sept 2026 |
₹58,423.96 Cr | 6742.0 | 734 | 119 | +18.2% | - | 16.2% | 484.0 |
|
Coromandel Internat…
Sept 2026 |
₹57,802.43 Cr | 1972.0 | 10,348 | 523 | +70.5% | - | 5.1% | 108.7 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores